James Gordon

Stock Analyst at JP Morgan

(1.78)
# 2,005
Out of 4,667 analysts
7
Total ratings
80%
Success rate
17.29%
Average return
Main Sectors:
Top Industries:

Stocks Rated by James Gordon

argenx SE
Nov 4, 2024
Maintains: Overweight
Price Target: $640$670
Current: $591.82
Upside: +13.21%
Genmab
Aug 20, 2024
Downgrades: Neutral
Price Target: n/a
Current: $20.45
Upside: -
FibroGen
Apr 7, 2021
Upgrades: Neutral
Price Target: n/a
Current: $0.35
Upside: -